Malignant Abnormalities in Male BRCA Mutation Carriers-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Malignant Abnormalities in Male BRCA Mutation Carriers

Published:2018-06-01 Issue:6 Volume:4 Page:872
ISSN:2374-2437
Container-title:JAMA Oncology
language:en
Short-container-title:JAMA Oncol

Author:

Mano Roy¹²,Tamir Shlomit³,Kedar Inbal⁴,Benjaminov Ofer³,Baniel Jack¹²,Tabachnik Tzlil¹,Margel David¹²

Affiliation:

1. Department of Urology, Rabin Medical Center, Petach Tikva, Israel

2. Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel

3. Department of Imaging, Rabin Medical Center, Petach Tikva, Israel

4. The Raphael Recanati Genetics Institute, Rabin Medical Center, Petach Tikva, Israel

Publisher

American Medical Association (AMA)

Subject

Oncology,Cancer Research

Reference6 articles.

1. Risks of cancer in BRCA1-mutation carriers.;Ford;Lancet,1994

2. Cancer risks in BRCA2 mutation carriers.;Breast Cancer Linkage;J Natl Cancer Inst,1999

3. Cancer risks for male carriers of germline mutations in BRCA1 or BRCA2: a review of the literature.;Liede;J Clin Oncol,2004

4. Germline BRCA mutations are associated with higher risk of nodal involvement, distant metastasis, and poor survival outcomes in prostate cancer.;Castro;J Clin Oncol,2013

5. Targeted prostate cancer screening in BRCA1 and BRCA2 mutation carriers: results from the initial screening round of the IMPACT study.;Bancroft;Eur Urol,2014

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Los olvidados: Non-BRCA variants associated with Hereditary breast cancer in Mexican population;2024-03-28

2. Male Breast Cancer: a Review on Diagnosis, Treatment, and Survivorship;Current Oncology Reports;2024-01

3. Assessment of medical knowledge toward genetic testing for individuals with hereditary breast and ovarian cancer syndrome in Brazil;Preventive Medicine Reports;2023-10

4. Clinical risk management of breast, ovarian, pancreatic, and prostatic cancers for BRCA1/2 variant carriers in Japan;Journal of Human Genetics;2023-04-24

5. Prostate cancer risk, screening and management in patients with germline BRCA1/2 mutations;Nature Reviews Urology;2023-01-04

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3